David C. Gale
Geen lopende functies
Loopbaan van David C. Gale
Eerdere bekende functies van David C. Gale
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INTERSECT ENT, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2007 | 01-08-2009 |
| ARTIVION, INC. | Hoofd Techniek/Wetenschap/O&O | 06-01-2012 | - |
Opleiding van David C. Gale
| The University of Alabama | Doctorate Degree |
| Auburn University | Graduate Degree |
| The University of Manchester | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARTIVION, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
- Beurs
- Insiders
- David C. Gale
- Ervaring
